VAK694

BIOLOGICAL2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Allergic RhinitisAsthma

Phase 1

To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma

CompletedNCT01568762

Novartis PharmaceuticalsAsthma

Start: 2010-10-31Updated: 2020-12-21

Phase 2

Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis

CompletedNCT00929968

Novartis PharmaceuticalsAllergic Rhinitis

Start: 2009-06-30Updated: 2020-12-19